Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin and Crestor for Diabetic Polyneuropathy
NCT02129231Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Feb 2012
- Primary completion
- Jan 2014
- Modality
- Implantable Devices, Transdermal Patches, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of Vytorin, rosuvastatin in diabetic polyneuropathy (DPN), sponsored by Universidad de Guadalajara. Started Feb 2012; status: completed.
02
Drugs
Vytorinrosuvastatin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT02129231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02129231.